SCHEMBL7567134

SCHEMBL7567134

CC1CCC(C(C)C)C(OC(=O)C(=O)c2ccccc2)C1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
HPGD P15428 2/20 0.59
LMNA P02545 2/20 0.53
CYP19A1 P11511 2/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
NPSR1 Q6W5P4 4/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
NPC1 O15118 1/20 0.48
MITF O75030 1/20 0.48
TP53 P04637 1/20 0.48
MAPK1 P28482 1/20 0.48
HTT P42858 1/20 0.48
RAB9A P51151 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MAPT P10636 1/20 0.48
TSHR P16473 1/20 0.48
P2RX4 Q99571 1/20 0.48
TRPM8 Q7Z2W7 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18759153 1.00 ALDH1A1 (0.59) ALDH1A1HPGDLMNACYP19A1CA1
SCHEMBL9015221 1.00 ALDH1A1 (0.59) ALDH1A1HPGDLMNACYP19A1CA1
Menthyl Benzoate SCHEMBL15498193 0.86 ALDH1A1 (0.69) ALDH1A1HPGDLMNACYP19A1CA1
Menthyl Benzoate SCHEMBL17407563 0.86 ALDH1A1 (0.69) ALDH1A1HPGDLMNACYP19A1CA1
Menthyl Benzoate SCHEMBL18708099 0.86 ALDH1A1 (0.69) ALDH1A1HPGDLMNACYP19A1CA1
Menthyl Benzoate SCHEMBL3885473 0.86 ALDH1A1 (0.69) ALDH1A1HPGDLMNACYP19A1CA1
Menthyl Benzoate SCHEMBL29093424 0.85 ALDH1A1 (0.67) ALDH1A1HPGDLMNACYP19A1CA1
SCHEMBL17836855 0.84 ALDH1A1 (0.48) ALDH1A1HPGDLMNACYP19A1CA1
SCHEMBL16036976 0.84 ALDH1A1 (0.48) ALDH1A1HPGDLMNACYP19A1CA1
SCHEMBL5783542 0.84 ALDH1A1 (0.48) ALDH1A1HPGDLMNACYP19A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2822682-B1 MICROCAPSULES AND USES THEREOF FIRMENICH & CIE (CH) 2017-04-26 EP claimed
US-9334464-B2 Microcapsules and uses thereof FIRMENICH SA (CH) 2016-05-10 US claimed
EP-2822682-A1 MICROCAPSULES AND USES THEREOF Firmenich SA (CH) 2015-01-14 EP claimed
US-20140323376-A1 MICROCAPSULES AND USES THEREOF FIRMENICH SA (CH) 2014-10-30 US claimed
CN-103958047-A Microcapsules and their use FIRMENICH & CIE 2014-07-30 CN claimed
WO-2013079435-A1 MICROCAPSULES AND USES THEREOF FIRMENICH SA (CH) 2013-06-06 WO claimed
EP-4711010-A2 PRO-PERFUME COMPOSITIONS Firmenich SA (CH) 2026-03-18 EP disclosed
US-20250263631-A1 PRO-PERFUME COMPOSITIONS FIRMENICH SA (CH) 2025-08-21 US disclosed
US-12325839-B2 Pro-perfume compositions FIRMENICH SA (CH) 2025-06-10 US disclosed
US-12264295-B2 Encapsulated pro-perfume compounds FIRMENICH SA (CH) 2025-04-01 US disclosed
US-20230093639-A1 PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT FIRMENICH SA (CH) 2023-03-23 US disclosed
US-20230032098-A1 ENCAPSULATED PRO-PERFUME COMPOUNDS FIRMENICH SA (CH) 2023-02-02 US disclosed
US-20230024269-A1 Pro-Perfume Compositions FIRMENICH SA (CH) 2023-01-26 US disclosed
WO-2013079435-A1 MICROCAPSULES AND USES THEREOF FIRMENICH SA (CH) 2013-06-06 WO disclosed
WO-2013067519-A2 INSECT AND TICK G-COUPLED RECEPTORS USEFUL AS TARGETS FOR INSECTICIDES AND COMPOUNDS AND REAGENTS IDENTIFIED USING THE SAME PURDUE RESEARCH FOUNDATION (US) 2013-05-10 WO disclosed
EP-0746551-B1 OPTICALLY PURE 4-ARYL-2-HYDROXYTETRONIC ACIDS UNIV OHIO STATE RES FOUND (US) 2002-09-04 EP disclosed
EP-0746551-A1 OPTICALLY PURE 4-ARYL-2-HYDROXYTETRONIC ACIDS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 1996-12-11 EP disclosed
US-5504108-A ANTIAGGLOMERANTS, ANTIARTHRITIC AGENTS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 1996-04-02 US disclosed
WO-1995023139-A1 OPTICALLY PURE 4-ARYL-2-HYDROXYTETRONIC ACIDS THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 1995-08-31 WO disclosed
US-5399721-A Anticoagulant; prepared from aldehyde THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 1995-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230093639-A1 PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT PORCN, FAAH2, FASN ALDH1A1 817/4885HPGD 281/4885LMNA 2789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.